Neocis manufactures and markets Yomi, a robotic surgical system cleared by the U.S. Food and Drug Administration that assists clinicians during all phases of dental implant placement. The Yomi platform has received a total of 16 FDA 510(k) clearances and provides streamlined digital planning and haptic guidance of surgical instrumentation. Neocis reports that more than 40,000 implants have been placed with robotic assistance and that a dental implant is placed with the system approximately every six minutes. Led by CEO Alon Mozes, the company is based in Miami, FL. The company intends to use newly raised funds to expand operations and broaden its business reach. The article does not disclose revenue or other financial metrics beyond the recent financing. Neocis manufactures and markets Yomi, dentistry’s first and only FDA-cleared robotic surgical system that assists clinicians during preoperative planning and intraoperative procedures via streamlined digital planning and haptic guidance. The platform enables accurate, efficient implant placement, is often used for flapless, less invasive procedures, and has assisted in the placement of more than 20,000 implants since 2016. Founded in 2009 and based in Miami, Neocis collaborates with leading clinicians to develop technologies that advance patient care. The company has raised more than $160 million in total funding since its founding and recently completed an oversubscribed $40M financing. Neocis will use the new capital to accelerate research and development, bolster marketing and educational initiatives, and expand its sales, clinical support, and business optimization teams. The business is backed by strategic and venture investors including Intuitive Ventures, Mithril Capital Management, DFJ Growth, Norwest Venture Partners, Vivo Capital, Section 32, and robotics pioneer Fred Moll. Neocis develops Yomi, a haptic robotic guidance and navigation system for dental implant planning and intra-operative instrument guidance. Yomi is the first and only FDA‑cleared robot-assisted surgical system for dental implant surgery and has been used to place more than 2,700 implants. The system enables minimally invasive, flapless implant procedures and provides preoperative planning software plus navigational guidance intended to improve precision, speed recovery, and reduce patient pain. Yomi is also being used at Boston University Henry M. Goldman School of Dental Medicine and the West Virginia University School of Dentistry to train clinicians. Neocis was founded in 2009 and is based in Miami; the company is led by co‑founder and CEO Alon Mozes. The company intends to expand the reach of its robotic-assisted system and further develop the Yomi technology platform. Neocis, based in Miami and led by Dr. Alon Mozes (CEO and Co-Founder), develops robotic systems for healthcare. The company manufactures and markets Yomi, a robot-assisted surgical platform for the dental industry. Yomi is FDA cleared and indicated for use in both the planning (pre-operative) and surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan procedures and offers navigational guidance of surgical instruments. It delivers surgical guidance through haptic robotic technology, software, and multisensory feedback to help achieve the correct position, angulation, and depth per the plan. Neocis closed a $30M equity financing and intends to use the funds to expand its commercialization and R&D efforts.

Total raised

$162M

Funding rounds

4

Latest round

Equity

Latest activity

Jan 2024